Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-019740
Filing Date
2020-02-13
Accepted
2020-02-13 08:34:10
Documents
1
Group Members
JEROME G. PFUNDMICHAEL L. SJOSTROMNEW EMERGING MEDICAL OPPORTUNITIES FUND III, L.P., AN EXEMPTED LIMITED PARTNERSHIPNEW EMERGING MEDICAL OPPORTUNITIES FUND III, L.P.: CAYMAN ISLANDSSECTORAL GP III, L.P., GENERAL PARTNER OF NEW EMERGING MEDICAL OPPORTUNITI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm207545-2_sc13g.htm SC 13G 84950
  Complete submission text file 0001104659-20-019740.txt   86811
Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8
Type: SC 13G

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91159 | Film No.: 20607135
SIC: 2834 Pharmaceutical Preparations